Literature DB >> 1255780

Burkitt's lymphoma in the Mengo Districts of Uganda: epidemiologic features and their relationship to malaria.

R H Morrow, A Kisuule, M C Pike, P G Smith.   

Abstract

An epidemiologic study of 123 patients residing in the Mengo Districts of Uganda, with onset of symptoms of diagnosed Burkitt's lymphoma (BL) in the period 1959-68, revealed a substantial decline in incidence of BL during that decade. Other significant findings included differences by ethnic group in age of patient at onset of BL, a change in the proportions of patients by ethnic group over the decade, a lower incidence rate of BL in the countries of higher altitude, and a seasonal pattern of onset. There was no evidence of the time space clustering previously reported for BL in Uganda. The changing pattern of BL in the Mengo Districts was consistent with the hypothesis that severe malaria infection not only is important in the development of BL but also precipitates onset.

Entities:  

Mesh:

Year:  1976        PMID: 1255780     DOI: 10.1093/jnci/56.3.479

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  16 in total

Review 1.  The company malaria keeps: how co-infection with Epstein-Barr virus leads to endemic Burkitt lymphoma.

Authors:  Ann M Moormann; Cynthia J Snider; Kiprotich Chelimo
Journal:  Curr Opin Infect Dis       Date:  2011-10       Impact factor: 4.915

2.  Involvement of gonadal steroids and gamma interferon in sex differences in response to blood-stage malaria infection.

Authors:  Amy Cernetich; Lindsey S Garver; Anne E Jedlicka; Pamela W Klein; Nirbhay Kumar; Alan L Scott; Sabra L Klein
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

3.  Familial Burkitt's lymphoma in Papua New Guinea.

Authors:  A Winnett; S J Thomas; B J Brabin; C Bain; M A Alpers; D J Moss
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

4.  Treatment of Burkitt lymphoma in equatorial Africa using a simple three-drug combination followed by a salvage regimen for patients with persistent or recurrent disease.

Authors:  Twalib Ngoma; Melissa Adde; Muheez Durosinmi; Jessie Githang'a; Yetunde Aken'Ova; Jane Kaijage; Oluwagbemiga Adeodou; Jamilla Rajab; Biobele J Brown; Lorenzo Leoncini; Kikkeri Naresh; Martine Raphael; Nina Hurwitz; Patricia Scanlan; Ama Rohatiner; David Venzon; Ian Magrath
Journal:  Br J Haematol       Date:  2012-07-30       Impact factor: 6.998

5.  Estrogen and progesterone affect responses to malaria infection in female C57BL/6 mice.

Authors:  Pamela W Klein; Judith D Easterbrook; Erin N Lalime; Sabra L Klein
Journal:  Gend Med       Date:  2008-12

Review 6.  Oncogenic mechanisms in Burkitt lymphoma.

Authors:  Roland Schmitz; Michele Ceribelli; Stefania Pittaluga; George Wright; Louis M Staudt
Journal:  Cold Spring Harb Perspect Med       Date:  2014-02-01       Impact factor: 6.915

7.  Denis Burkitt and the African lymphoma.

Authors:  I Magrath
Journal:  Ecancermedicalscience       Date:  2009-09-30

8.  Recurrent Plasmodium falciparum malaria infections in Kenyan children diminish T-cell immunity to Epstein Barr virus lytic but not latent antigens.

Authors:  Cynthia J Snider; Stephen R Cole; Kiprotich Chelimo; Peter Odada Sumba; Pia D M Macdonald; Chandy C John; Steven R Meshnick; Ann M Moormann
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

9.  A Role for RNA Viruses in the Pathogenesis of Burkitt's Lymphoma: The Need for Reappraisal.

Authors:  Corry van den Bosch
Journal:  Adv Hematol       Date:  2011-11-29

10.  T-helper 1 versus T-helper 2 lymphocyte immunodysregulation is the central factor in genesis of Burkitt lymphoma: hypothesis.

Authors:  Joseph Lubega
Journal:  Infect Agent Cancer       Date:  2007-05-17       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.